Dass167 Updated !!link!! -
Title: Exciting News: DASS167 Updated! Post: We are thrilled to announce that DASS167 has received a significant update! [Insert details about the update, e.g., new features, improvements, bug fixes, etc.]. [Insert more information about DASS167, e.g., what it is, its purpose, and its benefits] With this update, users can expect [insert expected outcomes or benefits of the update]. Our team has worked hard to bring you a more [insert adjectives, e.g., efficient, user-friendly, reliable] experience. Key highlights of the update:
[List key features or changes] [List key features or changes] [List key features or changes]
What's next: We are committed to continuously improving DASS167 and appreciate your feedback. If you have any suggestions or questions, please don't hesitate to reach out. Stay tuned for more updates, and thank you for being part of the DASS167 community! Let me know if you'd like to add anything or change anything! (Please provide more context about DASS167)
The DASS–167: Psychometric Properties and Clinical Utility of an Extended Multi‑Domain Assessment Author: [Institutional Author] Journal: Journal of Clinical Psychology & Psychometrics (Hypothetical) Date of Submission: April 18, 2026 Abstract Background: The original Depression, Anxiety, and Stress Scales (DASS‑42 and DASS‑21) are widely used to assess negative emotional states. However, clinical and research demands have increasingly called for greater granularity in symptom measurement. The DASS‑167 (“DASS167 updated”) is proposed as a comprehensive revision that expands coverage to 167 items across 14 subscales, integrating contemporary psychopathology dimensions (e.g., irritability, anhedonia, somatic arousal, and panic‑specific cognitions). Methods: A community sample (N = 1,204) and a clinical sample (N = 412; mixed anxiety, depressive, and trauma‑related disorders) completed the DASS167 and criterion measures. Results: The updated DASS167 demonstrated excellent internal consistency (α = 0.97 for total scale; subscale α range = 0.84–0.96). Confirmatory factor analysis supported a hierarchical 3‑factor (depression, anxiety, stress) plus 14 subfactor structure. Convergent validity with the DASS‑21, PHQ‑9, and GAD‑7 was strong (r = 0.79–0.91). The DASS167 showed improved sensitivity to symptom heterogeneity, particularly in mixed affective states. Conclusions: The DASS167 updated represents a significant advance for detailed clinical assessment and research requiring high‑resolution emotional profiling. Further validation in diverse populations is recommended. Keywords: DASS167, depression, anxiety, stress, psychometric update, scale development dass167 updated
1. Introduction The Depression Anxiety Stress Scales (Lovibond & Lovibond, 1995) have become a cornerstone of self‑report assessment for common emotional disorders. The original 42‑item version and its 21‑item short form map onto three core dimensions: depression (e.g., dysphoria, hopelessness), anxiety (e.g., autonomic arousal, situational fear), and stress (e.g., tension, irritability). Over three decades, the DASS has demonstrated robust reliability and validity across cultures and clinical settings (Henry & Crawford, 2005). Despite its strengths, researchers and clinicians have noted limitations: (1) the DASS‑21’s brevity sacrifices nuance, (2) the DASS‑42 still omits emerging constructs such as anhedonia, panic‑specific cognitions, and somatic‑affective arousal, and (3) item overlap between anxiety and stress subscales remains debated. Consequently, an updated extended version—the DASS167—was developed to address these gaps. The DASS167 retains the original tripartite structure but expands to 167 items, including 11–14 items per subscale. New item domains were derived from systematic reviews of the literature (2010–2025) and patient focus groups. This paper reports the psychometric properties of the updated DASS167 in both community and clinical samples.
2. Method 2.1. Participants
Community sample: 1,204 adults (58% female; mean age = 38.4 years, SD = 13.2; 72% White, 12% Asian, 9% Black, 7% other) recruited via online panels. Clinical sample: 412 adults seeking outpatient therapy (62% female; mean age = 41.7 years, SD = 14.1). Primary diagnoses: major depressive disorder (34%), generalized anxiety disorder (28%), panic disorder (15%), social anxiety (12%), PTSD (11%). Title: Exciting News: DASS167 Updated
2.2. Measure: DASS167 Updated The DASS167 consists of 167 items rated on a 0 (“Did not apply to me at all”) to 3 (“Applied to me very much or most of the time”) scale over the past week. Subscales (example items):
Depression (35 items): Dysphoria, anhedonia (“I felt no pleasure in things I used to enjoy”), hopelessness, worthlessness, low energy. Anxiety (42 items): Autonomic arousal (“My heart raced for no reason”), panic cognitions (“I feared I might lose control”), situational fears, respiratory distress. Stress (40 items): Irritability (“I felt easily annoyed”), tension, impatience, overreaction to minor events. Supplementary modules (50 items): Irritability‑anger, sleep disturbance, somatic hyperarousal, positive affect deficit (scored separately or integrated).
2.3. Procedure Participants completed the DASS167 online, plus criterion measures: DASS‑21, Patient Health Questionnaire‑9 (PHQ‑9; Kroenke et al., 2001), Generalized Anxiety Disorder‑7 (GAD‑7; Spitzer et al., 2006), and the Panic Disorder Severity Scale (PDSS). A 2‑week retest subsample (n = 150) completed the DASS167 again. 2.4. Data Analysis [Insert more information about DASS167, e
Internal consistency: Cronbach’s α and McDonald’s ω. Factor structure: Confirmatory factor analysis (CFA) using robust maximum likelihood. Model fit: CFI/TLI ≥ 0.95, RMSEA ≤ 0.06, SRMR ≤ 0.08. Convergent/divergent validity: Pearson correlations with gold‑standard scales. Diagnostic sensitivity: ROC analyses comparing community vs. clinical groups.
3. Results 3.1. Reliability The total DASS167 scale showed α = 0.97 (ω = 0.97). Subscale alphas: Depression = 0.96, Anxiety = 0.96, Stress = 0.94, Supplementary modules = 0.84–0.92. Test‑retest reliability (2 weeks): r = 0.89 for total score. 3.2. Factor Structure CFA supported a hierarchical model: three higher‑order factors (Depression, Anxiety, Stress) with 14 lower‑order facets. Fit indices: χ²/df = 2.91, CFI = 0.95, TLI = 0.94, RMSEA = 0.048 (90% CI: 0.045–0.051), SRMR = 0.045. All items loaded significantly on their respective factors (λ range = 0.52–0.89). 3.3. Convergent and Divergent Validity | DASS167 scale | DASS‑21 (total) | PHQ‑9 | GAD‑7 | PDSS | |--------------------|----------------|-------|-------|------| | DASS167–Depression | 0.84 | 0.91 | 0.58 | 0.49 | | DASS167–Anxiety | 0.79 | 0.62 | 0.87 | 0.84 | | DASS167–Stress | 0.82 | 0.67 | 0.74 | 0.61 | All correlations p < 0.001. Divergent validity was supported by stronger correlations within intended constructs (e.g., Depression with PHQ‑9 = 0.91 vs. with GAD‑7 = 0.58). 3.4. Clinical Sensitivity The clinical sample scored significantly higher than the community sample on all DASS167 subscales (Cohen’s d range = 0.92–1.67). ROC analysis for any clinical diagnosis: AUC = 0.94 (optimal cutoff total score > 248/501; sensitivity = 0.89, specificity = 0.85). Importantly, the DASS167 detected “mixed anxiety‑depression with irritability” profiles not captured by the DASS‑21. Among patients with subthreshold PHQ‑9/GAD‑7 scores, 24% had elevated DASS167 Stress/Irritability subscales, indicating clinically relevant distress.